← Back to Search

Behavioral Intervention

tDCS+CIMT for Stroke

N/A

Waitlist Available

Led By Yanlong Song, PhD

Research Sponsored by University of Texas Southwestern Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

5-17 years of age, including 5-year-old and 17-year-old

Formal diagnosis of hemiplegic cerebral palsy

Timeline

Screening 3 weeks

Treatment Varies

Follow Up with the first day of the intervention defined as day 1, this measure will be assessed in one of the three days before day 1, on day 15 or day 16 or day 17, and on day 181 or day 182 or day 183.

Awards & highlights

Study Summary

This trial aims to test if using transcranial direct current stimulation (tDCS) can improve the effectiveness of constraint-induced movement therapy (CIMT) in children with HCP. They also

Who is the study for?

This trial is for children with Hemiplegic Cerebral Palsy (HCP), a condition affecting one side of the body. Participants should be able to follow instructions and attend multiple therapy sessions. Children with metal in their head, skin conditions on the scalp, seizures, or those who can't tolerate having their stronger arm restrained are excluded.Check my eligibility

What is being tested?

The study is testing whether tDCS (a non-invasive brain stimulation technique) can improve how well constraint-induced movement therapy (CIMT) works for improving motor skills in kids with HCP. Some will receive real tDCS while others get a sham treatment as part of the research design.See study design

What are the potential side effects?

tDCS may cause mild discomfort, itching, tingling or a burning sensation on the scalp during application. There's also a small risk of fatigue or headache after treatment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 5 and 17 years old.

Select...

I have been diagnosed with hemiplegic cerebral palsy.

Select...

I have movement and feeling issues in one arm and hand.

Select...

I can undergo study procedures by myself.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ with the first day of the intervention defined as day 1, this measure will be assessed in one of the three days before day 1, on day 15 or day 16 or day 17, and on day 181 or day 182 or day 183.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~with the first day of the intervention defined as day 1, this measure will be assessed in one of the three days before day 1, on day 15 or day 16 or day 17, and on day 181 or day 182 or day 183.

This trial's timeline: 3 weeks for screening, Varies for treatment, and with the first day of the intervention defined as day 1, this measure will be assessed in one of the three days before day 1, on day 15 or day 16 or day 17, and on day 181 or day 182 or day 183. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

fine manual dexterity

gross manual dexterity

Secondary outcome measures

finger touch sensitivity

quality of upper extremity skill

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: tDCS+CIMTExperimental Treatment2 Interventions

Participants will receive concurrent anodal tDCS (20 minutes, 1mA~2mA) and CIMT (2 hours) five days a week for three weeks in a row.

Group II: sham+CIMTPlacebo Group2 Interventions

Participants will receive concurrent sham tDCS and CIMT (2 hours) five days a week for three weeks in a row.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

tDCS

2017

Completed Phase 2

~640

CIMT

2021

N/A

~90

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Texas Southwestern Medical CenterLead Sponsor

1,048 Previous Clinical Trials

1,054,225 Total Patients Enrolled

10 Trials studying Stroke

3,158 Patients Enrolled for Stroke

Children's HealthOTHER

7 Previous Clinical Trials

659 Total Patients Enrolled

Yanlong Song, PhDPrincipal InvestigatorUniversity of Texas Southwestern Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals aged 55 and above eligible to participate in this research study?

"This investigation is seeking participants over 5 years old but under the age of 17."

Answered by AI

Are individuals currently able to apply and participate in this ongoing research study?

"As per details on clinicaltrials.gov, the current trial is not open for enrollment. Initially posted on April 1st, 2024 and last updated on February 1st, 2024, this study does not currently seek participants. Nonetheless, there are numerous other trials seeking candidates with a total of 180 ongoing studies actively looking for patient involvement at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Cerebral pAlsy Motor Promotion With Transcranial Direct Current Stimulation (CAMP-tDCS)

Yanlong Song 2024. "Cerebral pAlsy Motor Promotion With Transcranial Direct Current Stimulation (CAMP-tDCS)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06239675.

All > Cerebral Palsy > Tdcs